Molecular epidemiology of β-thalassemia in Pakistan: far reaching implications
- PMID: 22200002
- PMCID: PMC3243455
Molecular epidemiology of β-thalassemia in Pakistan: far reaching implications
Abstract
β-thalassaemia, an autosomal recessive hemoglobinopathy, is one of the commonest genetically transmitted disorders throughout the world. Collective measures including carrier identification, genetic counseling and prenatal diagnosis are required for preventing β-thalassemia. To achieve this objective, Identification of the spectrum of genetic mutations, especially for various ethnic backgrounds in Pakistan is necessary. Therefore, we designed a cross sectional prospective study to identify the frequency of various gene mutations in different ethnic groups of Pakistan. Over a 5-year period, DNA from 648 blood samples [including specimens of chorionic villus sampling (CVS)] were analyzed for the twelve most common β-thalassemia mutations found in the Pakistani population by a Multiplex amplification refractory mutation system (ARMS). The most common mutation identified was Intervening Sequence 1-5 (IVS 1-5 (G-C)); accounting for 40.89% mutated alleles, and was represented in all ethnic groups. 15.7 % of the β-thalassemia alleles were found to have Frameshift 8-9 (Fr 8-9) as the second most common mutation Other common genetic defects responsible for β-thalassemia: IVS 1-1 (G-T) was found in 8.17%, Codon-30 (Cd-30 (G-C)) 8.02%, Codon-5(Cd-5 (-CT)) contributed 2.16% and Deletion 619 base pair (Del 619bp) affected 11.11% were found in Pakistan. This large study adds to the pre-existing data in Pakistan. Knowledge of the predominant mutation in a given ethnic group will not only help in developing a short panel of (population-specific) primers of mutations thereby providing a cost-effective method for prenatal diagnosis and also help the clinicians to counsel regarding blood transfusion regimen/ pregnancy termination.
Keywords: Pakistan; genetic mutations; molecular epidemiology; β-thalassemia.
Figures
Similar articles
-
Molecular epidemiology of β-thalassemia in Pakistan: Far reaching implications.Indian J Hum Genet. 2012 May;18(2):193-7. doi: 10.4103/0971-6866.100762. Indian J Hum Genet. 2012. PMID: 23162295 Free PMC article.
-
Genetic diversity of beta-thalassemia mutations in Pakistani population.J Pak Med Assoc. 2000 Sep;50(9):293-6. J Pak Med Assoc. 2000. PMID: 11043018
-
Regional and ethnic distribution of beta thalassemia mutations and effect of consanguinity in patients referred for prenatal diagnosis.J Coll Physicians Surg Pak. 2007 Mar;17(3):144-7. J Coll Physicians Surg Pak. 2007. PMID: 17374299
-
Molecular genetics and prenatal diagnosis of beta thalassemia to control transfusion dependent births in carrier Pakistani couples.J Pak Med Assoc. 2017 Jul;67(7):1030-1034. J Pak Med Assoc. 2017. PMID: 28770881
-
Prevention programmes and prenatal diagnosis for beta thalassemia in Pakistan: A narrative review.J Pak Med Assoc. 2021 Jan;71(1(B)):326-331. doi: 10.47391/JPMA.665. J Pak Med Assoc. 2021. PMID: 35157672 Review.
Cited by
-
A rare and novel mutation in a beta-globin gene of thalassemia patient of Pakistan: A case report.Ann Med Surg (Lond). 2022 Nov 17;84:104918. doi: 10.1016/j.amsu.2022.104918. eCollection 2022 Dec. Ann Med Surg (Lond). 2022. PMID: 36582856 Free PMC article.
-
High resolution melting curve analysis targeting the HBB gene mutational hot-spot offers a reliable screening approach for all common as well as most of the rare beta-globin gene mutations in Bangladesh.BMC Genet. 2018 Jan 2;19(1):1. doi: 10.1186/s12863-017-0594-3. BMC Genet. 2018. PMID: 29295702 Free PMC article.
-
The Spectrum of Beta-thalassemia Mutations in Couples Referred for Chorionic Villus Sampling at Bahawal Victoria Hospital, Bahawalpur.Cureus. 2018 Sep 7;10(9):e3265. doi: 10.7759/cureus.3265. Cureus. 2018. PMID: 30430054 Free PMC article.
-
Knowledge and Beliefs Regarding Thalassemia in an Urban Population.Cureus. 2019 Jul 29;11(7):e5268. doi: 10.7759/cureus.5268. Cureus. 2019. PMID: 31576261 Free PMC article.
-
Novel genetic therapeutic approaches for modulating the severity of β-thalassemia (Review).Biomed Rep. 2020 Nov;13(5):48. doi: 10.3892/br.2020.1355. Epub 2020 Sep 2. Biomed Rep. 2020. PMID: 32953110 Free PMC article. Review.
References
-
- Weatherall DJ, Clegg JB. Blackwell Sci. Fourth. Oxford: 2001. The Thalassemia Syndromes.
-
- Angastiniotis M, Modell B. Global epidemiology of hemoglobin disorders. Ann NY Acad Sci. 1998;850:251–69. - PubMed
-
- Ahmed S, Saleem M, Modell B, Petrou M. Screening extended families for genetic hemoglobin disorders in Pakistan. N Engl J Med. 2010;347:1162–68. - PubMed
-
- Cao A, Rosatelli MC, Galanello R. Control of β-thalassemia by carrier screening, genetic counselling and prenatal diagnosis: the Sardinian experience. Ciba Found Symp. 1996;197:137–51. discussion 151-5. - PubMed
-
- Karimi M, Jamalian N, Yarmohammadi H, Askarnejad A, Afrasiabi A, Hashemi A. Premarital screening for β-thalassemia in Southern Iran: options for improving the program. J Med Screen. 2007;14:62–6. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous